Cited by 239Alzheimer's disease research and treatmentsAutophagy in Disease and TherapyMitochondrial Function and Pathology

The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.

Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession

Open access

Liu, Dong, Pitta, Michael, Jiang, Haiyang, Lee, Jong-Hwan, Zhang, Guofeng, Chen, Xinzhi, Kawamoto, Elisa M., Mattson, Mark P.·2013·Neurobiology of Aging

DOI 10.1016/j.neurobiolaging.2012.11.020PMC PMC3596471

Open this paper in CoChat — free account

Abstract

Impaired brain energy metabolism and oxidative stress are implicated in cognitive decline and the pathologic accumulations of amyloid β-peptide (Aβ) and hyperphosphorylated tau in Alzheimer's disease (AD). To determine whether improving brain energy metabolism will forestall disease progress in AD, the impact of the β-nicotinamide adenine dinucleotide precursor nicotinamide on brain cell mitochondrial function and macroautophagy, bioenergetics-related signaling, and cognitive performance were studied in cultured neurons and in a mouse model of AD. Oxidative stress resulted in decreased mitochondrial mass, mitochondrial degeneration, and autophagosome accumulation in neurons. Nicotinamide preserved mitochondrial integrity and autophagy function, and reduced neuronal vulnerability to oxidative/metabolic insults and Aβ toxicity. β-Nicotinamide adenine dinucleotide biosynthesis, autophagy, and phosphatidylinositol-3-kinase signaling were required for the neuroprotective action of nicotinamide. Treatment of 3xTgAD mice with nicotinamide for 8 months resulted in improved cognitive performance, and reduced Aβ and hyperphosphorylated tau pathologies in hippocampus and cerebral cortex. Nicotinamide treatment preserved mitochondrial integrity, and improved autophagy-lysosome procession by enhancing lysosome/autolysosome acidification to reduce autophagosome accumulation. Treatment of 3xTgAD mice with nicotinamide resulted in elevated levels of activated neuroplasticity-related kinases (protein kinase B [Akt] and extracellular signal-regulated kinases) and the transcription factor cyclic adenosine monophosphate (AMP) response element-binding protein in the hippocampus and cerebral cortex. Thus, nicotinamide suppresses AD pathology and cognitive decline in a mouse model of AD by a mechanism involving improved brain bioenergetics with preserved functionality of mitochondria and the autophagy system.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2012.11.020

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Self-citation
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Self-citation
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Autophagy and Aging
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107

Flagged first, then by citations

Show all 101 references

Sorted by citations

Items 101–200 of 239

Involvement of GABAergic interneuron dysfunction and neuronal network hyperexcitability in Alzheimer's disease: Amelioration by metabolic switching
Mattson, M. P. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.01.006 · Cited by 33
Self-citation
Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain
Ramanathan, C., Lackie, T., Williams, D. H., Simone, P. S., Zhang, Y., & Bloomer, R. J. (2022) · Nutrients · doi:10.3390/nu14020300 · Cited by 33
Mitophagy impairment in neurodegenerative diseases: Pathogenesis and therapeutic interventions
Mani, S., Swargiary, G., & Chadha, R. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.01.001 · Cited by 33
The interplay between lipid and Aβ amyloid homeostasis in Alzheimer’s Disease: risk factors and therapeutic opportunities
García‐Viñuales, S., Sciacca, M. F. M., Lanza, V., Santoro, A. M., Grasso, G., Tundo, G. R., Sbardella, D., Coletta, M., Grasso, G., Rosa, C. L., et al. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105072 · Cited by 34
Boosting mitochondrial health to counteract neurodegeneration
Burtscher, J., Romani, M., Bernardo, G., Popa, T., Ziviani, E., Hummel, F. C., Sorrentino, V., & Millet, G. P. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102289 · Cited by 36
Autophagy and Cellular Senescence in Alzheimer's Disease: Key Drivers of Neurodegeneration
Hussain, M. S., Agrawal, N., Ilma, B., Rekha, M. M., Nayak, P. P., Kaur, M., Khachi, A., Goyal, K., Rekha, A., Gupta, S., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70503 · Cited by 35
Ex vivo protective effects of nicotinamide and 3‐aminobenzamide on rat synaptosomes treated with Aβ(1–42)
Turunç, E., Armağan, G., Uyanıkgil, Y., Kanıt, L., Koylu, E. O., & Yalçın, A. (2014) · Cell Biochemistry and Function · doi:10.1002/cbf.3049 · Cited by 31
Acute sources of mitochondrial NAD+ during respiratory chain dysfunction
Chinopoulos, C. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113218 · Cited by 29
Protective Effects of 1-Methylnicotinamide on Aβ1–42-Induced Cognitive Deficits, Neuroinflammation and Apoptosis in Mice
Fu, L., Liu, C., Chen, L., Lv, Y., Meng, G., Hu, M. Y., Long, Y., Hong, H., & Tang, S. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-09830-1 · Cited by 30
Autophagy system as a potential therapeutic target for neurodegenerative diseases
Cui, M., Yoshimori, T., & Nakamura, S. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105308 · Cited by 29
Mitochondrial mechanisms in Alzheimer’s disease: Quest for therapeutics
Kalani, K., Chaturvedi, P., Chaturvedi, P., Verma, V. K., Lal, N., Awasthi, S. K., & Kalani, A. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103547 · Cited by 28
Influence of Genetic Background on Apathy-Like Behavior in Triple Transgenic AD Mice.
Pardossi-Piquard, R., Lauritzen, I., Bauer, C., Sacco, G., Robert, P., & Checler, F. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160404120106 · Cited by 22
Nicotinamide phosphoribosyltransferase delays cellular senescence by upregulating SIRT 1 activity and antioxidant gene expression in mouse cells
Khaidizar, F. D., Nakahata, Y., Kume, A., Sumizawa, K., Kohno, K., Matsui, T., & Bessho, Y. (2017) · Genes to Cells · doi:10.1111/gtc.12542 · Cited by 27
Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
Magalhães, J. D., Fão, L., Vilaça, R., Cardoso, S. M., & Rego, A. C. (2021) · Biomedicines · doi:10.3390/biomedicines9111625 · Cited by 29
Brain regional synchronous activity predicts tauopathy in 3×TgAD mice
Liu, D., Lu, H., Stein, E. A., Zhou, Z., Yang, Y., & Mattson, M. P. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.016 · Cited by 28
Self-citation
Centella asiatica Alters Metabolic Pathways Associated With Alzheimer’s Disease in the 5xFAD Mouse Model of ß-Amyloid Accumulation
Speers, A. B., García‐Jaramillo, M., Feryn, A. B., Matthews, D. G., Lichtenberg, T., Caruso, M. A., Wright, K. M., Quinn, J. F., Stevens, J. F., Maier, C. S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.788312 · Cited by 29
Progresses in both basic research and clinical trials of NAD+ in Parkinson’s disease
Maria Jose Perez, J., Baden, P., & Deleidi, M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111499 · Cited by 26
Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?
Kim, C.-K., Sachdev, P. S., & Braidy, N. (2022) · Aging and Disease · doi:10.14336/ad.2021.0705 · Cited by 27
Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases
Mekhaeil, M., Dev, K. K., & Conroy, M. J. (2022) · Cancers · doi:10.3390/cancers14030687 · Cited by 25
Neuronanomedicine for Alzheimer’s and Parkinson’s disease: Current progress and a guide to improve clinical translation
Boyton, I., Valenzuela, S. M., Collins‐Praino, L. E., & Care, A. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.004 · Cited by 23
Antiaging Therapies, Cognitive Impairment, and Dementia
Wahl, D., Anderson, R. M., & Couteur, D. G. L. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz135 · Cited by 25
GTP energy dependence of endocytosis and autophagy in the aging brain and Alzheimer’s disease
Santana-Martínez, R. A., Pinky, P. D., Harlan, B. A., & Brewer, G. J. (2023) · GeroScience · doi:10.1007/s11357-022-00717-x · Cited by 26
Big Brains, Meat, Tuberculosis, and the Nicotinamide Switches: Co-Evolutionary Relationships with Modern Repercussions?
Williams, A. C., & Dunbar, R. (2013) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s12838 · Cited by 24
Mitochondrial and Autophagic Regulation of Adult Neurogenesis in the Healthy and Diseased Brain
Büeler, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073342 · Cited by 26
Inhibition of Early Upstream Events in Prodromal Alzheimer’s Disease by Use of Targeted Antioxidants
Prasad, K. N., & Bondy, S. C. (2014) · Current Aging Science · doi:10.2174/1874609807666140804115633 · Cited by 24
Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease
Grill, J. D., Tam, S. P., Thai, G. T., Vides, B., Pierce, A. L., Green, K. N., Gillen, D. L., Teng, E., Kremen, S. A., Beigi, M., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000210152 · Cited by 23
Mitochondrial NUDIX hydrolases: A metabolic link between NAD catabolism, GTP and mitochondrial dynamics
Long, A., Klimova, N., & Kristián, T. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.009 · Cited by 26
Nicotinamide Improves Functional Recovery via Regulation of the RAGE/JNK/NF-κB Signaling Pathway after Brain Injury
Alam, S., Réhman, S. U., & Kim, M. O. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020271 · Cited by 22
Orientin Improves Cognition by Enhancing Autophagosome Clearance in an Alzheimer’s Mouse Model
Zhong, Y., Zheng, Q.-Y., Sun, C., Zhang, Z., Han, K., & Jia, N. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01353-5 · Cited by 22
Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer’s Disease: A Systematic Review of Preclinical Studies
Hosseini, L., Mahmoudi, J., Pashazadeh, F., Salehi‐Pourmehr, H., & Sadigh‐Eteghad, S. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01842-6 · Cited by 23
Nicotinamide attenuates the decrease in dendritic spine density in hippocampal primary neurons from 5xFAD mice, an Alzheimer’s disease animal model
Kim, H.-J., Kim, B., Kim, H.-S., & Cho, J. (2020) · Molecular Brain · doi:10.1186/s13041-020-0565-x · Cited by 21
Initial brain aging: heterogeneity of mitochondrial size is associated with decline in complex I-linked respiration in cortex and hippocampus
Thomsen, K., Yokota, T., Hasan‐Olive, M. M., Dreyer, N. S., Fakouri, N. B., Desler, C., Regnell, C. E., Larsen, S., Rasmussen, L. J., Dela, F., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.004 · Cited by 20
Application of Response Surface Method for Preparation, Optimization, and Characterization of Nicotinamide Loaded Solid Lipid Nanoparticles
Vakilinezhad, M. A., Tanha, S., Montaseri, H., Dinarvand, R., Azadi, A., & Javar, H. A. (2018) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2018.029 · Cited by 20
Activation of β2-adrenergic Receptor Ameliorates Amyloid-β-induced Mitophagy Defects and Tau Pathology in Mice
Chai, G., Wu, J., Gong, J., Zhou, J.-L., Jiang, Z.-Q., Yi, H., Gu, Y., Huang, H.-H., Yao, Z.-Y., Zhang, Y., et al. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.09.020 · Cited by 23
Nicotinamide riboside supplementation ameliorated post-ovulatory oocyte quality decline
Li, H., Wang, H., Xu, J., Zeng, X., Sun, Y., & Yang, Q. (2022) · Reproduction · doi:10.1530/rep-22-0095 · Cited by 21
Early Mitochondrial Defects in the 5xFAD Mouse Model of Alzheimer’s Disease
Sharma, N., Banerjee, R., & Davis, R. L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220884 · Cited by 20
Pandanus amaryllifolius Exhibits In Vitro Anti-Amyloidogenic Activity and Promotes Neuroprotective Effects in Amyloid-β-Induced SH-SY5Y Cells
Tan, M. A., Ishikawa, H., & An, S. S. A. (2022) · Nutrients · doi:10.3390/nu14193962 · Cited by 19
Autophagy mediates phase transitions from cell death to life
Han, K., Kim, J., & Choi, M. Y. (2015) · Heliyon · doi:10.1016/j.heliyon.2015.e00027 · Cited by 19
Nutraceutical Strategies for Targeting Mitochondrial Dysfunction in Neurodegenerative Diseases
Davì, F., Iaconis, A., Cordaro, M., Paola, R. D., & Fusco, R. (2025) · Foods · doi:10.3390/foods14132193 · Cited by 20
Pharmacologic reversal of advanced Alzheimer’s disease in mice and identification of potential therapeutic nodes in human brain
Chaubey, K., Vázquez‐Rosa, E., Tripathi, S. J., Shin, M., Yu, Y., Dhar, M., Chakraborty, S., Yamakawa, M., Wang, X., Sridharan, P. S., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102535 · Cited by 21
Mitophagy pathways and Alzheimer's disease: From pathogenesis to treatment
Pan, X.-J., Misrani, A., Tabassum, S., & Yang, L. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.04.007 · Cited by 18
Virtual Screening in the Identification of Sirtuins’ Activity Modulators
Abbotto, E., Scarano, N., Piacente, F., Millo, E., Cichero, E., & Bruzzone, S. (2022) · Molecules · doi:10.3390/molecules27175641 · Cited by 18
Studying the Relationship of Intermittent Fasting and β-Amyloid in Animal Model of Alzheimer’s Disease: A Scoping Review
Nasaruddin, M. L., Halim, S. A. S. A., & Kamaruzzaman, M. A. (2020) · Nutrients · doi:10.3390/nu12103215 · Cited by 19
NAD + reverses Alzheimer’s neurological deficits via regulating differential alternative RNA splicing of EVA1C
Ai, R., Mao, L., Jin, X., Campos‐Marques, C., Zhang, S., Pan, J., Lagartos-Donate, M. J., Cao, S., Barros‐Santos, B., Nóbrega‐Martins, R., et al. (2025) · Science Advances · doi:10.1126/sciadv.ady9811 · Cited by 20
Mitophagy in Neurodegenerative Diseases: Mechanisms of Action and the Advances of Drug Discovery
Yang, P., Wen, S., Wang, X., Hu, X., Zhao, M., Wang, A., Wu, Y., Ouyang, L., & Wang, G. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01779 · Cited by 17
Age-related impairment of cerebral blood flow response to K ATP channel opener in Alzheimer’s disease mice with presenilin-1 mutation
Liu, D., Ahmet, I., Griess, B., Tweedie, D., Greig, N. H., & Mattson, M. P. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20964233 · Cited by 18
Self-citation
Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer’s Disease Dementia
Araki, W., & Kametani, F. (2022) · Antioxidants · doi:10.3390/antiox11010132 · Cited by 17
Nicotinamide as potential biomarker for Alzheimer’s disease: A translational study based on metabolomics
Dalmasso, M. C., Arán, M., Galeano, P., Perin, S., Giavalisco, P., Adami, P. V. M., Novack, G. V., Castaño, E. M., Cuello, A. C., Scherer, M., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1067296 · Cited by 16
Progress in mitochondrial and omics studies in Alzheimer’s disease research: from molecular mechanisms to therapeutic interventions
Liao, Z., Zhang, Q., Ren, N., Zhao, H., & Zheng, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1418939 · Cited by 15
Delineating the Role of Mitophagy Inducers for Alzheimer Disease Patients
Wang, W., Han, R., He, H., Wang, Z., Luan, X., Li, J., Feng, L., Chen, S., Aman, Y., & Xie, C. (2021) · Aging and Disease · doi:10.14336/ad.2020.0913 · Cited by 15
Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment
Wu, C., Kupferschmid, A. C., Liu, C., McManus, A. J., Kivisäkk, P., Galler, J. A., Schwab, N. A., DesRuisseaux, L. A., Williams, V. J., Gerber, J. A., et al. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70023 · Cited by 18
A systematic review of the therapeutic potential of nicotinamide adenine dinucleotide precursors for cognitive diseases in preclinical rodent models
Qader, M. A., Hosseini, L., Abolhasanpour, N., Oghbaei, F., Maghsoumi‐Norouzabad, L., Salehi‐Pourmehr, H., Fattahi, F., & Sadeh, R. N. (2025) · BMC Neuroscience · doi:10.1186/s12868-025-00937-9 · Cited by 16
Mitochondrial Dysfunction in Aging: Future Therapies and Precision Medicine Approaches
Jia, L., Wei, Z., Luoqian, J., Wang, X., & Huang, C. (2025) · MedComm – Future Medicine · doi:10.1002/mef2.70026 · Cited by 14
Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management
Singh, B., Mahajan, S., Abdella, S., Khan, R., & Garg, S. (2025) · Medicinal Research Reviews · doi:10.1002/med.70013 · Cited by 16
Pharmacokinetic and pharmacodynamic assessment of oral nicotinamide in the NEAT clinical trial for early Alzheimer’s disease
Ketron, G. L., Grün, F., Grill, J. D., Feldman, H., Rissman, R. A., & Brewer, G. J. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01693-y · Cited by 14
Nicotinamide improves sevoflurane-induced cognitive impairment through suppression of inflammation and anti-apoptosis in rat.
Wang, Y., & Zuo, M. (2015) · PubMed Central · Cited by 14
A New Insight into an Alternative Therapeutic Approach to Restore Redox Homeostasis and Functional Mitochondria in Neurodegenerative Diseases
Hyun, D., & Lee, J. (2021) · Antioxidants · doi:10.3390/antiox11010007 · Cited by 15
Self-citation
Pharmacodynamics, Network Pharmacology, and Pharmacokinetics of Chinese Medicine Formula 9002A in the Treatment of Alzheimer’s Disease
Tang, C., Fang, Z., Chu, D., Zhang, L., Tang, Y., Zhou, J., Fang, R., Ying, J., Wang, F., Zhou, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.849994 · Cited by 14
Big brains, meat, tuberculosis and the nicotinamide switches: Co-evolutionary relationships with modern repercussions on longevity and disease?
Williams, A. C., & Dunbar, R. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.04.003 · Cited by 15
Mitophagy in Alzheimer's disease and its potential as a therapeutic target
Wei, J., Xiao, T., Lyu, J., Zhao, Y., Zhang, Y., Du, X., He, Y., Zhao, M., Yang, X., Yao, Y., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107162 · Cited by 13
Mitochondria at the crossroads: Quality control mechanisms in neuronal senescence and neurodegeneration
Zheng, Y., Yang, J., Li, X., Qi, L., Zheng, Z., Kong, J., Zhang, G., & Guo, Y. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106862 · Cited by 14
Self-citation
The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma
Silva, S. G. N. E., Occhiutto, M. L., & Costa, V. P. (2023) · European Journal of Ophthalmology · doi:10.1177/11206721231161101 · Cited by 14
Nanomedicine-Driven Therapeutic Interventions of Autophagy and Stem Cells in The Management of Alzheimer’s Disease
Alhodieb, F. S., Rahman, M. A., Barkat, M. A., Alanezi, A. A., Barkat, H. A., Hadi, H. A., Harwansh, R. K., & Mittal, V. (2023) · Nanomedicine · doi:10.2217/nnm-2022-0108 · Cited by 13
Risks and rewards of targeting NAD+ homeostasis in the brain
Li, C., & Wu, L. E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111545 · Cited by 14
Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders
Helman, T. J., & Braidy, N. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00989-0 · Cited by 13
Natural products as geroprotectors: An autophagy perspective
Raj, S. D., Fann, D. Y., Wong, E. S. P., & Kennedy, B. K. (2021) · Medicinal Research Reviews · doi:10.1002/med.21815 · Cited by 12
Targeting autophagy in astrocytes: a potential for neurodegenerative disease intervention
Potokar, M., & Jorgačevski, J. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1584767 · Cited by 14
Nicotinamide Phosphoribosyltransferase Positive Allosteric Modulators Attenuate Neuronal Oxidative Stress
Gordon-Blake, J. M., Ratia, K. M., Weidig, V., Reddy, V. G., Ackerman-Berrier, M. S., Penton, C., Musku, S. R., Alves, E. T. M., Driver, T. G., Tai, L. M., et al. (2024) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00391 · Cited by 11
Long-term atorvastatin or the combination of atorvastatin and nicotinamide ameliorate insulin resistance and left ventricular diastolic dysfunction in a murine model of obesity
Yang, X., Xiong, T., Dong, N., Wang, T., Zhong, H., Tang, S., Mao, Y., Zhu, G., & Wang, D. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115132 · Cited by 11
Decreased plasma nicotinamide and altered NAD+ metabolism in glial cells surrounding Aβ plaques in a mouse model of Alzheimer's disease
Sekiya, M., Sakakibara, Y., Hirota, Y., Ito, N., Chikamatsu, S., Takei, K., Nishijima, R., & Iijima, K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106694 · Cited by 10
An Update on Autophagy as a Target in the Treatment of Alzheimer’s Disease
Sose, P. M., Doshi, G., & Kale, P. P. (2023) · Current Drug Targets · doi:10.2174/1389450124666230417104325 · Cited by 10
Neuronal ablation of GHSR mitigates diet-induced depression and memory impairment via AMPK-autophagy signaling-mediated inflammation
Wang, H., Shen, Z., Wu, C., Ji, P., Noh, J. Y., Geoffroy, C. G., Kim, S.-J., Threadgill, D. W., Li, J., Zhou, Y., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1339937 · Cited by 9
Therapeutic application of nicotinamide: As a potential target for inhibiting fibrotic scar formation following spinal cord injury
Zhang, C., Shao, Q., Zhang, Y., Liu, W., Kang, J., Jin, Z., Huang, N., & Ning, B. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14826 · Cited by 11
Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases
Altay, Ö., Yang, H., Yıldırım, S., Bayram, C., Bolat, İ., Öner, S., Tozlu, Ö. Ö., Arslan, M. E., Hacımüftüoğlu, A., Shoaie, S., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12040927 · Cited by 9
Autofluorescence cascade nanozyme catalyzes in vivo ROS scavenging for precisive anti-neuroinflammation therapy
Du, X., Zhao, G., Fu, Y., Zhou, Y., Yang, L., Jiang, Z., Liu, S., Zhang, X., Zhu, K., Li, W., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163217 · Cited by 8
Autophagy–NAD+ axis: emerging insights into neuronal homeostasis and neurodegenerative diseases
Koçak, G., Dimas, M. M., Silva, L., Silva-Amaral, D., Sun, C., Cruddas, S., Barrett, T. G., Martins‐de‐Souza, D., Cunha‐Neto, E., Brocardo, P. S., et al. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1695486 · Cited by 8
Role of Autophagy and Mitophagy in Neurodegenerative Disorders
Kapil, L., Kumar, V., Kaur, S., Sharma, D., Singh, C., & Singh, A. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230327092855 · Cited by 9
The mTOR Signaling Pathway in Neurodegenerative Diseases
Francois, A., Vérité, J., Bilan, A. R., Janet, T., Calon, F., Fauconneau, B., Paccalin, M., & Page, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00011-6 · Cited by 8
A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy
Pupyshev, A. B., Короленко, Т. А., & Tikhonova, M. A. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0519-7 · Cited by 8
Alzheimer’s disease: a jigsaw puzzle comprised of different types of programmed cell death pieces
Wang, Y., Mu, D., Li, Y., Liu, C., Feng, J., Lai, Y., & Lou, G. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149861 · Cited by 7
Mitochondria as an Integrative Hub of Cellular Homeostasis and Stress Response
Mihaylova, V., Kovacheva, E., Gevezova, M., Sarafian, V. S., & Kazakova, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093871 · Cited by 10
Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner
Marmolejo-Garza, A., Châtre, L., Croteau, D. L., Herrón-Bedoya, A., Luu, M. D. A., Bernay, B., Pontin, J., Bohr, V. A., Boddeke, E., & Dolga, A. M. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106645 · Cited by 9
Mitostasis in age-associated neurodegeneration
Panda, M., Markaki, M., & Tavernarakis, N. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167547 · Cited by 7
A Genome-Wide Screen with Nicotinamide to Identify Sirtuin-Dependent Pathways in Saccharomyces cerevisiae
Choy, J. S., Qadri, B., Henry, L., Shroff, K., Bifarin, O. O., & Basrai, M. A. (2015) · G3 Genes Genomes Genetics · doi:10.1534/g3.115.022244 · Cited by 7
Nicotinamide effects on the metabolism of human fibroblasts and keratinocytes assessed by quantitative, label-free fluorescence imaging
Liu, Z., Chiang, C. ‐., Nip, J., Feng, L., Zhang, Y., Rocha, S., & Georgakoudi, I. (2021) · Biomedical Optics Express · doi:10.1364/boe.432561 · Cited by 7
Synthetic and Natural Bioactive Molecules in Balancing the Crosstalk among Common Signaling Pathways in Alzheimer’s Disease: Understanding the Neurotoxic Mechanisms for Therapeutic Intervention
Shah, A. J., Mir, P. A., Adnan, M., Patel, M. B., Maqbool, M., Mir, R. H., & Masoodi, M. H. (2023) · ACS Omega · doi:10.1021/acsomega.3c05662 · Cited by 11
Advances in Drug Discovery and Development in Geriatric Psychiatry
Conley, A. C., & NEWHOUSE, P. A. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0871-5 · Cited by 8
A Triple‐Role Nano‐Therapy by NADH@HMONs‐AAL for Precision Treatment of Cognitive Dysfunction Induced by Neuroinflammation through the Nose‐Brain Pathway
Du, X., Zhao, G., Zhou, Y., Yang, L., Jiang, Z., Liu, S., Zhang, X., Lu, M., Han, L., & Gu, W. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402129 · Cited by 6
Advancement of disease-modifying therapy of Alzheimer’s disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer’s disease
Wu, J., Geng, C., Liu, L., & Tang, Y. (2025) · Medicine Plus · doi:10.1016/j.medp.2025.100112 · Cited by 8
Autophagy and tau protein
Hamano, T., & Endo, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00006-x · Cited by 7
Guardians of homeostasis: Natural products target metabolic reprogramming in Alzheimer’s disease
Zhang, Z., Xu, H., Zhao, F., Han, Z., Pan, J., Li, M., Guan, W., Jiang, P., Hao, Z., Zhang, Y., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.103005 · Cited by 5
Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets
Jia, Y.-J., Ge, Y., Li, B., Yang, Y., Chen, H., Liu, J., Guo, J., Yu, J., Ye, K., Wang, J., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-2991-7 · Cited by 6
Postnatal and Juvenile Fluoxetine Treatment Evokes Sex-Specific, Opposing Effects on Mood-Related Behavior, Gene Expression, Mitochondrial Function, and Dendritic Architecture in the Rat Medial Prefrontal Cortex
Ghai, U., Chachra, P., Mendon, S., Janakiraman, B., Fanibunda, S. E., Sarkar, A., Gohil, D., Jayaprasad, A. B., Kukkemane, K., Singh, V. K., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.04.026 · Cited by 7
MoNET: an R package for multi-omic network analysis
Li, J., Chen, F., Liang, H., & Yan, J. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab722 · Cited by 4
Chemical conversion of nicotinamide into type I positive allosteric modulator of α7 nAChRs
Li, X., Xie, W., Wang, X., Huang, Z., Bian, X., Wang, K., & Sun, Q. L. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.05.046 · Cited by 4
Optical Redox Imaging of Ex Vivo Hippocampal Tissue Reveals Age-Dependent Alterations in the 5XFAD Mouse Model of Alzheimer’s Disease
Xu, H. N., Gourmaud, S., Podsednik, A., Li, X., Zhao, H., Jensen, F. E., Talos, D. M., & Li, L. Z. (2022) · Metabolites · doi:10.3390/metabo12090786 · Cited by 4
Targeted Metabolomic Analysis of the Eye Tissue of Triple Transgenic Alzheimer’s Disease Mice at an Early Pathological Stage
Shen, L., Tang, X., Zhang, H., Zhuang, H., Jing, L., Zhao, Y., & Liu, X. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03533-2 · Cited by 4
Mode of administration influences plasma levels of active Centella asiatica compounds in 5xFAD mice while markers of neuroinflammation remain unaltered
Speers, A. B., Wright, K. M., Brandes, M. S., Kedjejian, N. E., Matthews, D. G., Caruso, M. A., Harris, C., Koike, S., Nguyen, T. T. M., Quinn, J. F., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1277626 · Cited by 4
Macroautophagy and chaperone-mediated autophagy in aging
Maduna, T., du Toit, A., & Loos, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817990-1.00018-4 · Cited by 5
Calorie Restriction Mimetics: Progress and Potential
Roth, G. S., & Ingram, D. K. (2015) · Healthy ageing and longevity · doi:10.1007/978-3-319-14830-4_10 · Cited by 5

Authors: Liu, D., Pitta, M., Jiang, H., Lee, J.-H., Zhang, G., Chen, X., Kawamoto, E. M., & Mattson, M. P.
Affiliations: National Institute on Aging (US)
Konkuk University (KR)
National Institutes of Health (US)
Corresponding author: Mattson, Mark P.
ORCID: Liu, Dong
Jiang, Haiyang
Zhang, Guofeng
Chen, Xinzhi
Kawamoto, Elisa M.
Mattson, Mark P.
Venue: Neurobiology of Aging
Publisher: Elsevier BV
Published: 2013-06
Volume: 34
Issue: 6
Pages: 1564-1580
ISSN: 0197-4580 (ISSN-L)
DOI: 10.1016/j.neurobiolaging.2012.11.020
PMC: PMC3596471
OpenAlex: W1996656477
Cited by: 238
References: 101
Citations by year: 2026: 11 · 2025: 29 · 2024: 23 · 2023: 19 · 2022: 21 · 2021: 37 · 2020: 16 · 2019: 17 · 2018: 17 · 2017: 13 · 2016: 10 · 2015: 10 · 2014: 8 · 2013: 7
FWCI: 5.36
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neurobiology of Aging (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Intramural Research Program of the National Institute on Aging
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords: nicotinamide, Alzheimer's disease, brain energy metabolism, mitochondrial function, autophagy, oxidative stress, amyloid-beta, hyperphosphorylated tau, 3xTg-AD mice, cognitive decline, phosphatidylinositol 3-kinase signaling, AMPK, lysosomal acidification, neuroprotection, hippocampus
MeSH terms: Alzheimer Disease, Animals, Autophagy, Cells, Cultured, Cognition Disorders, Disease Models, Animal, Energy Metabolism, Mice, Inbred C57BL, Mice, Transgenic, Neurons, Niacinamide, Vitamin B Complex, Oxidative Stress, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks